Ablynx and Merck & Co. Partner to Develop Nanobody® Ion Channel Modulators
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 10 (Table of Contents)
Published: 20 Oct-2012
DOI: 10.3833/pdr.v2012.i10.1822 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a deal potentially worth up to €456...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS